In our previous article Can Ganoderma for Hypertension Help Much? , we introduced the basic relationship between Ganoderma lucidum and blood pressure regulation. Here we take a deeper look at the pharmacological evidence.

Antihypertensive Effects Observed in Animal Studies

Modern pharmacological studies have shown that Ganoderma lucidum exhibits antihypertensive activity in animal models. In experiments on spontaneously hypertensive rats, oral administration of Ganoderma lucidum mycelium was associated with reduced blood pressure and lower cholesterol levels in the liver and plasma.

The Role of Ganoderma Polysaccharides

Recent research suggests that Ganoderma lucidum polysaccharides may help regulate superoxide dismutase activity in the aortic smooth muscle of hypertensive rats, supporting the body's antioxidant defenses and protecting blood vessel health.

Triterpenoids and ACE Inhibition

The antihypertensive potential of Ganoderma lucidum is believed to be partly related to the triterpenoids it contains. Several triterpenoid compounds — including Ganoderma lucidum A, K, S, and ganodermaol A and B — isolated from a 70% methanolic extract, have demonstrated angiotensin-converting enzyme (ACE) inhibitory activity in laboratory studies.

Since elevated ACE activity contributes to blood vessel constriction, the ACE-inhibitory properties of these triterpenoids may indirectly support healthy blood pressure levels.

Antioxidant and Free Radical Scavenging Activity

These findings suggest that the antioxidant and free radical scavenging activity of Ganoderma lucidum may be an important mechanism supporting its blood pressure benefits observed in preclinical studies.

Summary

Preclinical evidence indicates that Ganoderma lucidum may support healthy blood pressure through multiple pathways, including antioxidant protection, ACE inhibition, and lipid regulation. While these findings are promising, further human clinical studies are needed. Consult a healthcare professional before using Ganoderma supplements.